• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用分子对接分析鉴定靶向Fyn激酶的新型抑制剂

Identification of novel inhibitor targeting Fyn kinase using molecular docking analysis.

作者信息

Nedunchezhian Dharani, Langeswaran Kulanthaivel, Santhoshkumar Sundar

机构信息

Department of Biotechnology and Bioinformatics,Bishop Heber College,Bharathidasan University,Tiruchirapalli,Tamil Nadu,India.

Cancer Genetics and Molecular Biology Laboratory, Department of Bioinformatics, Science Campus, Alagappa University, Karaikudi, Tamil Nadu, India.

出版信息

Bioinformation. 2019 Jun 15;15(6):419-424. doi: 10.6026/97320630015419. eCollection 2019.

DOI:10.6026/97320630015419
PMID:31312079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6614121/
Abstract

Identification of tyrosine Fyn kinase inhibitor is recognized as an effective and feasible therapeutic measure in reducing consequences of memory loss disorder Alzheimer's. The present investigation has been attempted with an objective to find out a novel potent inhibitor with similar homological structure to Fyn kinase using structure based in silico screening measure. Such derived structure was compared with natural data base pool and were systematically analyzed. Ligand based interaction was also tested and evaluated. We applied a molecular dynamic simulation technique to validate the stability of the identified complexes and to understand the ligand binding mechanism. Results provide information on the characteristics of novel and potent inhibitor for tyrosinase Fyn kinase protein so as to develop an innovative strategy to treat AD.

摘要

鉴定酪氨酸Fyn激酶抑制剂被认为是减轻记忆丧失疾病阿尔茨海默病后果的一种有效且可行的治疗措施。本研究旨在通过基于结构的计算机筛选方法,寻找一种与Fyn激酶具有相似同源结构的新型强效抑制剂。将这种推导得到的结构与天然数据库进行比较并进行系统分析。还对基于配体的相互作用进行了测试和评估。我们应用分子动力学模拟技术来验证所鉴定复合物的稳定性,并了解配体结合机制。结果提供了有关酪氨酸酶Fyn激酶蛋白新型强效抑制剂特性的信息,以便制定治疗阿尔茨海默病的创新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e65/6614121/b4df195e1c91/97320630015419F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e65/6614121/54e401d31680/97320630015419F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e65/6614121/b4df195e1c91/97320630015419F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e65/6614121/54e401d31680/97320630015419F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e65/6614121/b4df195e1c91/97320630015419F2.jpg

相似文献

1
Identification of novel inhibitor targeting Fyn kinase using molecular docking analysis.利用分子对接分析鉴定靶向Fyn激酶的新型抑制剂
Bioinformation. 2019 Jun 15;15(6):419-424. doi: 10.6026/97320630015419. eCollection 2019.
2
Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer's Disease via Fyn Tyrosine Kinase Inhibition.通过抑制Fyn酪氨酸激酶对罂粟碱作为阿尔茨海默病虚拟药物候选物的计算洞察。
Mol Biotechnol. 2025 Jul;67(7):2743-2757. doi: 10.1007/s12033-024-01236-0. Epub 2024 Jul 14.
3
Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.揭示具有抑制酪蛋白激酶 Fyn 潜力的植物成分:针对阿尔茨海默病的综合虚拟筛选方法。
J Alzheimers Dis. 2023;96(2):827-844. doi: 10.3233/JAD-230828.
4
Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.Fyn 酪氨酸激酶在阿尔茨海默病患者神经元中引起淀粉样前体蛋白 Tyr682 磷酸化。
Cells. 2020 Jul 30;9(8):1807. doi: 10.3390/cells9081807.
5
Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications.阿尔茨海默病中的Fyn激酶:揭示分子机制与治疗意义
Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18.
6
Fyn kinase inhibition as a novel therapy for Alzheimer's disease.抑制Fyn激酶作为治疗阿尔茨海默病的新疗法。
Alzheimers Res Ther. 2014 Feb 5;6(1):8. doi: 10.1186/alzrt238. eCollection 2014.
7
Targeting Fyn Kinase in Alzheimer's Disease.靶向阿尔茨海默病中的 Fyn 激酶。
Biol Psychiatry. 2018 Feb 15;83(4):369-376. doi: 10.1016/j.biopsych.2017.06.004. Epub 2017 Jun 13.
8
AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.用于鉴定阿尔茨海默病Tau-Fyn SH3相互作用抑制剂的AlphaScreen高通量筛选和活细胞生物发光共振能量转移(BRET)分析
J Biomol Screen. 2014 Dec;19(10):1338-49. doi: 10.1177/1087057114547232. Epub 2014 Aug 25.
9
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
10
Structure of human Fyn kinase domain complexed with staurosporine.与星形孢菌素复合的人源Fyn激酶结构域
Biochem Biophys Res Commun. 2006 Aug 4;346(3):840-4. doi: 10.1016/j.bbrc.2006.05.212. Epub 2006 Jun 13.

引用本文的文献

1
Digital Alchemy: The Rise of Machine and Deep Learning in Small-Molecule Drug Discovery.数字炼金术:小分子药物发现中机器学习与深度学习的兴起
Int J Mol Sci. 2025 Jul 16;26(14):6807. doi: 10.3390/ijms26146807.
2
In silico screening of Fyn kinase inhibitors using classification-based QSAR model, molecular docking, molecular dynamics and ADME study.基于分类的 QSAR 模型、分子对接、分子动力学和 ADME 研究的 Fyn 激酶抑制剂的计算机筛选。
Mol Divers. 2024 Aug;28(4):2217-2228. doi: 10.1007/s11030-024-10905-w. Epub 2024 Jun 17.

本文引用的文献

1
ADME properties evaluation in drug discovery: in silico prediction of blood-brain partitioning.药物发现中的 ADME 性质评估:血脑分配的计算预测。
Mol Divers. 2018 Nov;22(4):979-990. doi: 10.1007/s11030-018-9866-8. Epub 2018 Aug 6.
2
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.注意缺陷多动障碍患病率的系统评价和荟萃分析。
Pediatrics. 2015 Apr;135(4):e994-1001. doi: 10.1542/peds.2014-3482. Epub 2015 Mar 2.
3
Identification of new Fyn kinase inhibitors using a FLAP-based approach.
基于 FLAP 的方法鉴定新型 Fyn 激酶抑制剂。
J Chem Inf Model. 2013 Oct 28;53(10):2538-47. doi: 10.1021/ci4002553. Epub 2013 Sep 16.
4
Virtual screening using the ligand ZINC database for novel lipoxygenase-3 inhibitors.
Bioinformation. 2013 Jun 29;9(11):583-7. doi: 10.6026/97320630009583. Print 2013.
5
From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase.从轴突-胶质细胞信号传递到髓鞘形成:少突胶质细胞 Fyn 激酶的整合作用。
Cell Mol Life Sci. 2011 Jun;68(12):2003-12. doi: 10.1007/s00018-010-0616-z. Epub 2011 Jan 5.
6
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.多巴胺 D1 受体介导的 NMDA 受体插入依赖于前额皮质神经元中的 Fyn 激酶途径,而非 Src 激酶途径。
Mol Brain. 2010 Jun 22;3:20. doi: 10.1186/1756-6606-3-20.
7
Direct inhibition of the NOTCH transcription factor complex.直接抑制 NOTCH 转录因子复合物。
Nature. 2009 Nov 12;462(7270):182-8. doi: 10.1038/nature08543.
8
Identification of an alternatively spliced isoform of the fyn tyrosine kinase.Fyn酪氨酸激酶可变剪接异构体的鉴定。
Biochem Biophys Res Commun. 2002 Nov 8;298(4):501-4. doi: 10.1016/s0006-291x(02)02510-x.
9
Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420.纹状体富集磷酸酶61使Fyn在磷酸酪氨酸420处去磷酸化。
J Biol Chem. 2002 Jul 5;277(27):24274-9. doi: 10.1074/jbc.M111683200. Epub 2002 Apr 30.
10
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.药物研发环境中估算溶解度和渗透性的实验与计算方法。
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26. doi: 10.1016/s0169-409x(00)00129-0.